サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1584131

免疫毒素市場：タイプ別、送達方法別、適応症別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年～2032年

Immunotoxins Market, By Type, By Delivery Method, By Target Indication, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 303 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
免疫毒素市場：タイプ別、送達方法別、適応症別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年～2032年
出版日: 2024年11月04日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

免疫毒素の市場規模は2023年に1億4,290万米ドルとなり、2024年から2032年にかけてCAGR 8.90%で拡大

免疫毒素市場-市場力学

アムジェンやジェネンテックのような大手製薬会社は、毎年数十億米ドルを標的がん治療薬の開発に充てており、研究投資と戦略的パートナーシップの増加が免疫毒素市場のイノベーションを大きく後押ししています。米国国立がん研究所によると、2021年には米国で約190万人が新たにがんと診断される見込みであり、革新的な治療法の緊急性が浮き彫りになっています。アストラゼネカとメルクの提携による抗体薬物複合体技術の進展のような協力関係は、治療効果を高める上で極めて重要です。さらに、欧州連合（EU）のHorizon 2020プログラムは、免疫毒素に焦点を当てた数多くの研究イニシアチブに資金を提供しており、この分野の成長をさらに確実なものにしています。こうした共同研究が盛んになるにつれて、患者の予後を改善し、治療の選択肢を広げる新規免疫毒素の開発につながると期待されています。

免疫毒素市場 - 主要インサイト

弊社リサーチアナリストの分析によると、世界市場は予測期間（2024年~2032年）に約8.90%のCAGRで毎年成長すると推定されます。

タイプ別セグメントでは、モノクローナル抗体ベースの免疫毒素が2023年に最大の市場シェアを示すと予測されています。

送達方法別では、2023年には全身投与が主要タイプでした。

適応症別では、血液悪性腫瘍が2023年の主要タイプでした。

地域別では、北米が2023年の売上高でトップでした。

免疫毒素市場-セグメンテーション分析：

世界の免疫毒素市場は、タイプ、送達方法、適応症、エンドユーザー、地域に基づいてセグメント化されます。

市場はタイプによって、組み換え免疫毒素、キメラ抗原受容体（CAR）T細胞療法、モノクローナル抗体ベースの3つのカテゴリーに分けられます。モノクローナル抗体ベースの免疫毒素は、標的治療における有効性が確立されていることから市場シェアが最も高く、革新的な治療オプションを提供する組み換え免疫毒素がこれに続く。キメラ抗原受容体（CAR）T細胞療法は、大きな可能性を示して第3位にランクされています。

送達方法別では、全身投与と局所投与の2つのカテゴリーに分けられます。全身投与は広範囲のがんを効果的に治療できることから優先され、局所投与は副作用の少ない標的治療を提供することからそれに続く。どちらの方法も異なる治療ニーズや患者プロファイルに対応し、治療選択肢を拡大します。

免疫毒素市場 - 地理的洞察

免疫毒素市場の地域情勢を見ると、北米、欧州、アジア太平洋地域で大きな動きがあり、それぞれが市場力学に独自の貢献をしていることがわかる。北米、特に米国は、高度なヘルスケアインフラ、研究開発への高額投資、アムジェンやジェネンテックのような大手製薬企業の存在により、市場シェアをリードしています。米国国立がん研究所（National Cancer Institute）は、この地域で進行中の臨床試験と技術革新を示す免疫毒素療法の強力なパイプラインを強調しています。欧州も主要なプレーヤーであり、先進的治療に対する規制当局の支援や、ドイツや英国などの国々での顕著な発展により、精密医療が重視されるようになっています。一方、アジア太平洋地域は、特に中国やインドのような、政府がバイオテクノロジー研究に投資している国々において、がん罹患率の増加とヘルスケアへのアクセスの拡大が後押しし、有望な市場として台頭しつつあります。現地企業と国際企業との協力関係は、この地域の市場ポテンシャルをさらに高め、免疫毒素療法の世界の発展に貢献しています。

免疫毒素市場 - 競合情勢：

免疫毒素市場の競合情勢は、既存の製薬企業と革新的なバイオテクノロジー企業が混在しているのが特徴で、いずれも研究開発や戦略的提携を通じて市場シェアを争っています。アムジェン、ジェネンテック、イーライリリーなどの大手企業は、がん領域における豊富なリソースと専門知識を活用し、免疫毒素療法の開発と商業化に積極的に取り組んでいます。例えば、アムジェンがFDA（米国食品医薬品局）認可を取得した免疫毒素製剤ブリナツモマブ（Blincyto）は、ある種の白血病の治療においてベンチマークとなっており、この治療法の可能性を示しています。イミュノジェン社やステムシナジーセラピューティクス社などの新興企業も、ユニークな免疫毒素候補薬や新しい送達メカニズムで躍進しており、技術革新と競争圧力を促進しています。この市場では共同研究が一般的であり、例えば、バイオテクノロジー企業と学術機関との提携が研究努力を後押しし、免疫毒素の新たな応用や組み合わせを模索する臨床試験につながっています。このようなダイナミックな環境は、バイオテクノロジー研究への投資の増加や個別化医療の重視によってさらに後押しされており、免疫毒素市場は継続的な成長と発展を遂げるものと思われます。

目次

第1章 免疫毒素市場の概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 免疫毒素の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 免疫毒素の産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 免疫毒素市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 免疫毒素市場情勢

  • 免疫毒素市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 免疫毒素市場 - タイプ別

  • 概要
    • タイプ別のセグメントシェア分析
    • 組み換え免疫毒素
    • キメラ抗原受容体（CAR）T細胞療法
    • モノクローナル抗体ベースの免疫毒素

第8章 免疫毒素市場 - 送達方法別

  • 概要
    • 送達方法別のセグメントシェア分析
    • 全身投与
    • 局所投与

第9章 免疫毒素市場 - 適応症別

  • 概要
    • 適応症別のセグメントシェア分析
    • 固形腫瘍
    • 造血悪性腫瘍
    • 自己免疫疾患

第10章 免疫毒素市場 - エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 病院
    • がん研究機関
    • 専門クリニック

第11章 免疫毒素市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析 - 免疫毒素業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Amgen Inc.
    • AstraZeneca PLC
    • Bayer AG
    • Daiichi Sankyo Company, Limited
    • Eisai Co., Ltd.
    • Eli Lilly and Company
    • Genentech, Inc.
    • Immunomedics, Inc.（Gilead Sciences）
    • Johnson &Johnson
    • Merck &Co., Inc.
    • Novartis AG
    • Pfizer Inc.
    • Roche Holding AG
    • Sanofi SA
    • Seattle Genetics, Inc.
    • Takeda Pharmaceutical Company Limited
    • Others

第13章 アナリストの全方位展望

目次
Product Code: ANV4093

REPORT HIGHLIGHT

Immunotoxins Market size was valued at USD 142.90 Million in 2023, expanding at a CAGR of 8.90% from 2024 to 2032.

The Immunotoxins market, which focuses on targeted therapies combining antibodies with cytotoxic agents to selectively kill cancer cells, is gaining momentum due to the increasing prevalence of cancer and autoimmune diseases. With an estimated 1.9 million new cancer cases expected in the U.S. alone in 2024, the demand for effective treatments is on the rise. This growing need is spurred by advancements in biotechnology, leading to the development of more effective immunotoxin formulations that enhance therapeutic efficacy while minimizing side effects. However, challenges such as high production costs and stringent regulatory approvals can hinder market growth. Moreover, the complexity of immunotoxin mechanisms can lead to variability in patient responses, raising concerns about treatment consistency. Nevertheless, the expanding research pipeline and the exploration of combination therapies present significant opportunities for market expansion. Companies are increasingly investing in clinical trials and strategic collaborations to innovate and diversify their product offerings, positioning themselves to meet the evolving needs of patients and healthcare providers in the oncology landscape.

Immunotoxins Market- Market Dynamics

Increasing Investment in Research and Strategic Partnerships Fuels Innovation in the Film Capacitor Market

The increasing investment in research and strategic partnerships is significantly driving innovation in the immunotoxins market, with major pharmaceutical companies like Amgen and Genentech allocating billions annually to develop targeted cancer therapies. According to the National Cancer Institute, approximately 1.9 million new cancer cases were diagnosed in the U.S. in 2021, underscoring the urgent need for innovative treatments. Collaborations such as the partnership between AstraZeneca and Merck to advance antibody-drug conjugate technology are pivotal in enhancing therapeutic efficacy. Moreover, the European Union's Horizon 2020 program has funded numerous research initiatives focusing on immunotoxins, further solidifying the sector's growth. As these collaborations continue to flourish, they are expected to lead to the development of novel immunotoxins that improve patient outcomes and expand treatment options.

Immunotoxins Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2024-2032)

Based on Type segmentation, Monoclonal Antibody-Based Immunotoxins were predicted to show maximum market share in the year 2023

Based on Delivery Method segmentation, Systemic Administration was the leading type in 2023

Based on Target Indication segmentation, Hematologic Malignancies was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Immunotoxins Market- Segmentation Analysis:

The Global Immunotoxins Market is segmented on the basis of Type, Delivery Method, Target Indication, End-User, and Region.

The market is divided into three categories based on Type: Recombinant Immunotoxins, Chimeric Antigen Receptor (CAR) T-cell therapy, and Monoclonal Antibody-Based Immunotoxins. Monoclonal Antibody-Based Immunotoxins hold the highest market share due to their established efficacy in targeted therapies, followed by Recombinant Immunotoxins, which offer innovative treatment options. Chimeric Antigen Receptor (CAR) T-cell therapy ranks third, showcasing significant potential.

The market is divided into two categories based on the Delivery Method: Systemic Administration and Local Administration. Systemic Administration is prioritized due to its ability to treat widespread cancers effectively, while Local Administration follows, offering targeted treatment with fewer side effects. Both methods cater to different therapeutic needs and patient profiles, enhancing treatment options.

Immunotoxins Market- Geographical Insights

The geographical landscape of the Immunotoxins market reveals significant activity across North America, Europe, and Asia-Pacific, each contributing uniquely to market dynamics. North America, particularly the United States, leads in market share due to advanced healthcare infrastructure, high investment in research and development, and the presence of major pharmaceutical companies like Amgen and Genentech. The National Cancer Institute has highlighted a robust pipeline of immunotoxin therapies, indicating ongoing clinical trials and innovations in this region. Europe is also a key player, driven by regulatory support for advanced therapies and a growing emphasis on precision medicine, with notable developments in countries like Germany and the UK. Meanwhile, the Asia-Pacific region is emerging as a promising market, fueled by increasing cancer prevalence and expanding healthcare access, particularly in countries like China and India, where governments are investing in biotechnology research. Collaborative efforts between local firms and international companies further enhance the market potential in this region, contributing to the global advancement of immunotoxin therapies.

Immunotoxins Market- Competitive Landscape:

The competitive landscape of the Immunotoxins market is characterized by a mix of established pharmaceutical companies and innovative biotech firms, all vying for market share through research, development, and strategic collaborations. Major players such as Amgen, Genentech, and Eli Lilly are actively involved in developing and commercializing immunotoxin therapies, leveraging their extensive resources and expertise in oncology. For instance, Amgen's FDA-approved immunotoxin, blinatumomab (Blincyto), has set a benchmark in treating certain types of leukemia, illustrating the potential of this therapeutic approach. Emerging players, like ImmunoGen and StemSynergy Therapeutics, are also making strides with unique immunotoxin candidates and novel delivery mechanisms, fostering innovation and competitive pressure. Collaborations are common in this market; for example, partnerships between biotech firms and academic institutions are driving research efforts, leading to clinical trials that explore new applications and combinations of immunotoxins. This dynamic environment is further supported by increasing investments in biotechnology research and an emphasis on personalized medicine, positioning the Immunotoxins market for continued growth and advancement.

Recent Developments:

In April 2024, Invera Inc. and Astellas Pharma announced a collaboration to develop therapeutic bispecific antibodies. Astellas Pharma will utilize Invera's B-Body bispecific antibody platform to advance its research in bispecific therapeutic applications.

In January 2023, List Biological Labs, Inc. enhanced its bacterial therapeutic manufacturing capabilities by incorporating a new 500L bioreactor along with a tangential flow filtration system, aimed at increasing production efficiency and meeting growing demand for bacterial therapeutics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNOTOXINS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Amgen Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Daiichi Sankyo Company, Limited
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Genentech, Inc.
  • Immunomedics, Inc. (Gilead Sciences)
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Roche Holding AG
  • Sanofi S.A.
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited
  • Others

GLOBAL IMMUNOTOXINS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Recombinant Immunotoxins
  • Chimeric Antigen Receptor (CAR) T-Cell Therapy
  • Monoclonal Antibody-Based Immunotoxins

GLOBAL IMMUNOTOXINS MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

  • Systemic Administration
  • Local Administration

GLOBAL IMMUNOTOXINS MARKET, BY TARGET INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Solid Tumors
  • Hematological Malignancies
  • Autoimmune Diseases

GLOBAL IMMUNOTOXINS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Cancer Research Institutes
  • Specialty Clinics

GLOBAL IMMUNOTOXINS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Immunotoxins Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Immunotoxins Market Snippet by Type
    • 2.1.2. Immunotoxins Market Snippet by Delivery Method
    • 2.1.3. Immunotoxins Market Snippet by Target Indication
    • 2.1.4. Immunotoxins Market Snippet by End-User
    • 2.1.5. Immunotoxins Market Snippet by Country
    • 2.1.6. Immunotoxins Market Snippet by Region
  • 2.2. Competitive Insights

3. Immunotoxins Key Market Trends

  • 3.1. Immunotoxins Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Immunotoxins Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Immunotoxins Market Opportunities
  • 3.4. Immunotoxins Market Future Trends

4. Immunotoxins Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Immunotoxins Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Immunotoxins Market Landscape

  • 6.1. Immunotoxins Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Immunotoxins Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Recombinant Immunotoxins
    • 7.1.3. Chimeric Antigen Receptor (CAR) T-Cell Therapy
    • 7.1.4. Monoclonal Antibody-Based Immunotoxins

8. Immunotoxins Market - By Delivery Method

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Delivery Method, 2023 & 2032 (%)
    • 8.1.2. Systemic Administration
    • 8.1.3. Local Administration

9. Immunotoxins Market - By Target Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Target Indication, 2023 & 2032 (%)
    • 9.1.2. Solid Tumors
    • 9.1.3. Hematological Malignancies
    • 9.1.4. Autoimmune Diseases

10. Immunotoxins Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Cancer Research Institutes
    • 10.1.4. Specialty Clinics

11. Immunotoxins Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Immunotoxins Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Immunotoxins Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Immunotoxins Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Immunotoxins Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Immunotoxins Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Immunotoxins Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Amgen Inc.
    • 12.2.2. AstraZeneca PLC
    • 12.2.3. Bayer AG
    • 12.2.4. Daiichi Sankyo Company, Limited
    • 12.2.5. Eisai Co., Ltd.
    • 12.2.6. Eli Lilly and Company
    • 12.2.7. Genentech, Inc.
    • 12.2.8. Immunomedics, Inc. (Gilead Sciences)
    • 12.2.9. Johnson & Johnson
    • 12.2.10. Merck & Co., Inc.
    • 12.2.11. Novartis AG
    • 12.2.12. Pfizer Inc.
    • 12.2.13. Roche Holding AG
    • 12.2.14. Sanofi S.A.
    • 12.2.15. Seattle Genetics, Inc.
    • 12.2.16. Takeda Pharmaceutical Company Limited
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us